
Arctoris is a British biotechnology company providing automated laboratory research and data-generation services.
Official pages and third-party coverage in one index.
arctoris.com29 items across 28 mapped pages · Crawled Sep 29, 2026
Official pages and third-party coverage in one index
Accelerate Your Biologics Discovery with Arctoris’ Integrated and High-Precision Solutions. Capabilities Overview Arctoris brings unparalleled expertise and cutting-edge technology to biologics drug discovery. Our comprehensive services span from antibody generation and engineering to functional characterization and optimization. Utilizing our advanced Ulysses® platform, we deliver high-throughput, high-quality data that drives the development of next-generation biologic therapeutics.…
Enrich your Drug Discovery Data with Arctoris’ Precision Biophysics Solutions. Capabilities Overview Arctoris revolutionizes biophysics in drug discovery by providing unparalleled insights into molecular interactions. Our advanced technologies and expert team empower you to quantitatively evaluate complex interactions, including binary and ternary systems. With high-throughput capabilities and AI/ML-ready data, we elucidate binding mechanisms and kinetics…
Unlock the Complexities of Cellular Mechanisms with Arctoris’ Advanced Cell Biology Solutions. Capabilities Overview Arctoris brings cell biology to the forefront of drug discovery by offering comprehensive solutions that bridge molecular targets and physiological relevance. Our state-of-the-art platforms and expert team enable you to validate target engagement and assess functional activity within complex cellular systems,…
Empower Your Drug Discovery with Arctoris’ Exceptional Protein Science Expertise. Capabilities Overview At Arctoris, we understand that high-quality proteins are foundational to successful drug discovery. Our expert team specializes in the production, purification, and characterization of proteins, providing you with critical reagents for biochemical, biophysical, and structural studies. Utilizing advanced technologies and automation, we deliver…
Foundation Models and the Power of Proprietary Experimental Data In recent years, foundation models have revolutionised fields from natural language processing to image generation. Now, these powerful AI systems are transforming drug discovery. By learning generalisable patterns across chemical and biological data, foundation models are unlocking new opportunities to identify novel small molecules and biologics,…
Arctoris is featured as a series partner in the Biology for a Better Tomorrow digital series, an initiative created with the Royal Society of Biology to highlight how biological sciences are addressing global challenges and advancing innovation across healthcare, sustainability, and environmental protection. The series brings together researchers, academic institutions, and biotechnology companies to showcase…
Scalable drug discovery demands phenotypic data that is both mechanistically rich and compatible with high-throughput, AI/ML-driven analysis, yet conventional RNA-seq workflows remain difficult to scale…
The Therapeutic Potential of Macrocycles in Drug Discovery Structural and Conformational Properties: Macrocycles exhibit distinct physicochemical characteristics that differentiate them from conventional small molecules. Their cyclic architectures confer a degree of conformational rigidity while maintaining three-dimensional complexity. This combination enables well-defined interactions with biological targets. As a result, macrocycles often demonstrate high binding affinity and…
Oxford-headquartered Arctoris progresses programmes from target to hit, lead, and candidate with superior efficiency, accuracy, and confidence. Key to the company’s capabilities is the unique combination of robotics and data science, enabling better data to be generated faster and better decisions made earlier. Drug discovery is a series of decisions – which Target to focus on, which hit to progress,…
Arctoris was featured in a Drug Discovery World (DDW) webinar discussing how automated experimentation platforms can accelerate drug discovery, particularly during urgent global health challenges such as the COVID-19 pandemic. The presentation highlights how automated laboratory workflows can enable scientists to rapidly generate high-quality experimental data while maintaining reproducibility and scalability. By integrating robotics, automated…
Arctoris was featured in Fierce Biotech following a period of significant growth, highlighting the company’s expansion and the development of a strengthened executive leadership team. The article reports that Arctoris co-founder Tom Fleming, Ph.D., has taken on the role of CEO, succeeding co-founder Martin-Immanuel Bittner, M.D., Ph.D., who led the company from 2018 to early…
Arctoris was featured in Labiotech, in an article highlighting a collaboration between the Oxford-based automation company and Swiss software firm Molecule. The partnership aims to improve drug discovery by combining laboratory automation with digital tools designed to simplify the sharing and development of drug intellectual property. The collaboration addresses a key challenge facing the pharmaceutical…
Let’s Grow Together Arctoris is transforming drug discovery and we’re scaling fast – and we’re just getting started. If you’re ambitious, curious, and ready to make an impact, join us on this incredible growth journey. explore open roles Make a Difference. Be Part of Something Big. Join Arctoris, where scientific rigour, automation and data shapes…
At Arctoris, we’ve replaced manual bottlenecks with a high-speed, automated engine for drug discovery. We are truly doing now what the industry will embrace as the standard in the future. In addition to this exciting, innovative environment, Arctoris is a space that is as inclusive and friendly as it is scientifically rigorous. If your motivation…
Full time at Milton Park, full-time, Milton Park (HQ, UK)
Chief People Officer There’s a energy at Arctoris that’s genuinely hard to describe until you’ve felt it. We’re a team of scientists and problem-solvers who are deeply passionate about what we do. The team don’t just accept a challenge, they go looking for one! That shared drive creates something special: a workplace that’s fast-moving, intellectually…
Arctoris was founded to solve a fundamental problem in drug discovery: biology has not kept pace with the scale, rigor, and data quality modern science demands.
Contact Us
We accelerate the discovery of new medicines by combining the power of robotics, data science, and deep biological expertise to generate precise, reproducible, and AI-ready data.
Policies Date of last update: 2023-12-15 INTRODUCTION Arctoris Limited (“Arctoris”, “we” or “us”) respects your privacy and is committed to protecting your personal data. This privacy policy describes how Arctoris collects and uses personal data collected when you access our platforms and websites, including arctoris.com, when you otherwise access our experimental, analytical and computational services…
We accelerate the discovery of new medicines by combining the power of robotics, data science, and deep biological expertise to generate precise, reproducible, and AI-ready data.